Health care in India, at its finest, matches the standards of international best practice. The knowledge, skill and confidence of its doctors and nurses, the sophistication of available technology, quality of service and five-star hospitality compete with the best in the world. Its relatively low cost has made it an important player in the health tourism sector. However, at the other extreme, publicly funded health care services often do not...
More »SEARCH RESULT
Research on Bhopal gas victims waits, not drug trials on them by Abantika Ghosh
The Indian Council of Medical Research (ICMR) has posted an advertisement inviting, by December 31, research proposals on long-term effects of methyl isocyanate (MIC) gas on Bhopal’s residents. However, while it is yet to conduct this research 27 years after the Bhopal gas tragedy caused by MIC that left hundreds dead, data shows that the “gas patients” have been routinely used for clinical trials for new drugs at the Bhopal Memorial...
More »Panel suggests price control in Essential Drug List by Kounteya Sinha
Drug prices have shot up phenomenally in India over the past decade and a half. A Planning Commission's expert group says there was nearly 40% rise in all drug prices between 1996 and 2006, thanks to the nation's pricedecontrol policies of the 1990s. Citing a study conducted in 2008, the Commission's high-level expert group (HLEG) on universal health coverage, headed by Dr K Srinath Reddy, says during the same period...
More »Organic food linked to E. coli outbreak? by Smita Pandey
If you are a health food freak who lives on salads and swears by the benefits of organically grown raw vegetables, it's time for a reality check. In 16 countries across the globe, nearly 3,000 people have been sickened and 29 have died after eating raw vegetables contaminated by a group of bacteria collectively called Escherichia coli ( E. coli). Authorities first cited contaminated Spanish cucumbers as the culprit and now...
More »‘Superbug' still a global concern: WHO
-The Hindu The ‘New Delhi superbug' remains “a global concern” because of its resistance to all antibiotics available in the world, according to a senior WHO official. “The ‘New Delhi metallo-beta-lactamase-1' bacteria carrying these mechanisms is a gene that includes the possibility of making anti-microbials not effective,” the official, Carmem Lucia Pessoa Da Silva, said. The NDM-1 had already been identified in several patients and countries. The WHO launched the Global Infection...
More »